The GSK-3β and CDK-5 pathways are intricately linked to Aβ aggregation, leading to tau hyperphosphorylation through the increased activity of both GSK-3β and CDK-5, ultimately resulting in Aβ-induced tauopathy [29]. Here, CDK5 is linked to tauopathy.